Here's When Pfizer's CEO Says the Company Might Get Back to Generating High-Single-Digit Growth
Pfizer's business may be in better shape than investors think.
Here's When Pfizer's CEO Says the Company Might Get Back to Generating High-Single-Digit Growth
Overview
If it weren't for question marks about its future growth, Pfizer (NYSE: PFE) stock would undoubtedly be trading at a much higher price. Sales were down last year, and the stock has been floundering, struggling to gain much traction. Even though it looks persistently cheap, investors haven't been buying it, even for its dividend, which yields an astonishingly high rate of 6.6%. By comparison, the S&P 500 averages a yield of only 1.1%.
But what if Pfizer does have a path to return to growth? The company's management sees a brighter future ahead, and here's a look at when Pfizer might get back to delivering high-single-digit growth.
Image source: Getty Images.
Details
Source
Originally published at www.fool.com.
